{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:07:30Z","timestamp":1794103650961,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clineuro.2024.108523","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:32:07Z","timestamp":1726072327000},"page":"108523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5041-4410","authenticated-orcid":false,"given":"Khadija","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7679-7940","authenticated-orcid":false,"given":"Arsala Nadeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6206-9433","authenticated-orcid":false,"given":"Afia","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6875-4850","authenticated-orcid":false,"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-6816","authenticated-orcid":false,"given":"Duaa","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-5835","authenticated-orcid":false,"given":"Abdullah","family":"Mussarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9915-6145","authenticated-orcid":false,"given":"Maryam","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-8127","authenticated-orcid":false,"given":"Muhammad Owais","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-3390","authenticated-orcid":false,"given":"Hamid","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abyaz","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clineuro.2024.108523_bib1","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib2","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.clineuro.2024.108523_bib3","doi-asserted-by":"crossref","unstructured":"Wardlaw J.M., Murray V., Berge E., Del Zoppo G.J. Thrombolysis for acute ischaemic stroke. Cochrane Stroke Group, editor. Cochrane Database Syst Rev [Internet]. 2014 Jul 29 [cited 2023 Sep 5];2016(1). Available from: \u3008http:\/\/doi.wiley.com\/10.1002\/14651858.CD000213.pub3\u3009.","DOI":"10.1002\/14651858.CD000213.pub3"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108523_bib4","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/STROKEAHA.116.013644","article-title":"Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials","volume":"47","author":"Lees","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib5","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873221076968","volume":"7","author":"Turc","year":"2022","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.clineuro.2024.108523_bib6","unstructured":"Umerah C. o, Momodu II. Anticoagulation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jul 21]. Available from: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560651\/\u3009."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib8","article-title":"Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation","volume":"2014","author":"Salazar","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8A","key":"10.1016\/j.clineuro.2024.108523_bib9","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108523_bib10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jamaneurol.2022.4765","article-title":"Building evidence on safety of thrombolysis for patients undergoing direct oral anticoagulant treatment","volume":"80","author":"Mistry","year":"2023","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108523_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bcp.14171","article-title":"Direct oral anticoagulants uptake and an oral anticoagulation paradox","volume":"86","author":"Kennedy","year":"2020","journal-title":"Br. J. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108523_bib13","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00415-018-9061-y","article-title":"Management of patients with stroke treated with direct oral anticoagulants","volume":"265","author":"Seiffge","year":"2018","journal-title":"J. Neurol."},{"issue":"9921","key":"10.1016\/j.clineuro.2024.108523_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet Lond. Engl."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108523_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF","volume":"69","author":"Huisman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108523_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.2022.0948","article-title":"Association of recent use of non\u2013vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase","volume":"327","author":"Kam","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","article-title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","volume":"80","author":"Meinel","year":"2023","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108523_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.116.023940","article-title":"Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke","volume":"135","author":"Xian","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2024.108523_bib19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.clineuro.2024.108523_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025809","article-title":"Intravenous thrombolysis with alteplase at 0.6\u2009mg\/kg in patients with ischemic stroke taking direct oral anticoagulants","volume":"11","author":"Okada","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108523_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11940-021-00695-z","article-title":"Acute stroke treatment in an anticoagulated patient: when is thrombolysis an option?","volume":"23","author":"Siller","year":"2021","journal-title":"Curr. Treat. Options Neurol."},{"issue":"9958","key":"10.1016\/j.clineuro.2024.108523_bib22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet Lond. Engl."},{"issue":"13","key":"10.1016\/j.clineuro.2024.108523_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/CIRCULATIONAHA.115.015484","article-title":"Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome","volume":"132","author":"Seiffge","year":"2015","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.clineuro.2024.108523_bib24","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.2012.6756","article-title":"Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator","volume":"307","author":"Xian","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108523_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.23924","article-title":"Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin","volume":"74","author":"Mazya","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/jcbfm.2013.226","article-title":"Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke","volume":"34","author":"Ploen","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib27","first-page":"153","article-title":"Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia","volume":"110","author":"Sun","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108523_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ana.23558","article-title":"Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke","volume":"71","author":"Pfeilschifter","year":"2012","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108523_bib29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/STROKEAHA.110.604652","article-title":"Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice","volume":"42","author":"Pfeilschifter","year":"2011","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.clineuro.2024.108523_bib30","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/STROKEAHA.114.005316","article-title":"Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat","volume":"45","author":"Kono","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108523_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp-2020-325456","article-title":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"92","author":"Seiffge","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108523_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00392-013-0560-7","article-title":"Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban","volume":"102","author":"Steiner","year":"2013","journal-title":"Clin. Res. Cardiol."},{"issue":"19","key":"10.1016\/j.clineuro.2024.108523_bib33","doi-asserted-by":"crossref","first-page":"e1968","DOI":"10.1212\/WNL.0000000000009155","article-title":"Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort","volume":"94","author":"Barber","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108523_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1747493017701944","article-title":"Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - a national case collection","volume":"12","author":"Kermer","year":"2017","journal-title":"Int. J. Stroke J. Int Stroke Soc."},{"issue":"19","key":"10.1016\/j.clineuro.2024.108523_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.0000000000009156","article-title":"Idarucizumab before reperfusion therapy in stroke patients on dabigatran: no more cold sweat","volume":"94","author":"Dias","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108523_bib36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/STROKEAHA.119.028327","article-title":"Dabigatran reversal before intravenous tenecteplase in acute ischemic stroke","volume":"51","author":"Beharry","year":"2020","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5853\/jos.2017.00395","article-title":"Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice","volume":"19","author":"Seiffge","year":"2017","journal-title":"J. Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/STROKEAHA.116.014963","article-title":"Coagulation testing in acute ischemic stroke patients taking non-vitamin K antagonist oral anticoagulants","volume":"48","author":"Purrucker","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42466-021-00105-4","article-title":"Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban","volume":"3","author":"H\u00e4rtig","year":"2021","journal-title":"Neurol. Res Pract."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108523_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11239-020-02143-2","article-title":"Point-of-care testing of coagulation in patients treated with edoxaban","volume":"50","author":"H\u00e4rtig","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13054-017-1619-z","article-title":"Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants","volume":"21","author":"Ebner","year":"2017","journal-title":"Crit. Care Lond. Engl."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108523_bib42","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/STROKEAHA.115.010148","article-title":"Point-of-care testing of coagulation in patients treated with non-vitamin K antagonist oral anticoagulants","volume":"46","author":"Ebner","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2024.108523_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuroscience.2017.03.026","article-title":"Role of thrombin-PAR1-PKC\u03b8\/\u03b4 axis in brain pericytes in thrombin-induced MMP-9 production and blood-brain barrier dysfunction in vitro","volume":"350","author":"Machida","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108523_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ana.21924","article-title":"Blood-brain barrier breakdown and repair by Src after thrombin-induced injury","volume":"67","author":"Liu","year":"2010","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108523_bib45","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","article-title":"Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke)","volume":"48","author":"Barreto","year":"2017","journal-title":"Stroke"},{"issue":"17","key":"10.1016\/j.clineuro.2024.108523_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009507","article-title":"Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation","volume":"7","author":"Sakamoto","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108523_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/STROKEAHA.119.026426","article-title":"Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis","volume":"51","author":"Shahjouei","year":"2020","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108523_bib48","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.012","article-title":"Safety of recanalization therapy in patients with acute ischemic stroke under anticoagulation: a systematic review and meta-analysis","volume":"27","author":"Liu","year":"2018","journal-title":"J. Stroke Cereb. Dis. J. Natl. Stroke Assoc."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108523_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4103\/aian.aian_271_22","article-title":"Safety of recanalization therapy in acute ischemic stroke patients on direct oral anticoagulant therapy: an updated systematic review and meta-analysis","volume":"25","author":"Zhang","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108523_bib50","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1007\/s00415-023-11815-x","article-title":"Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis","volume":"270","author":"Liang","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2024.108523_bib51","doi-asserted-by":"crossref","unstructured":"ESOC 2022 \u2013 Late Breaking Science, Ongoing Trials & Young Stroke Physicians and Researchers. Eur Stroke J. 2022 May;7(1_suppl):546\u201388.","DOI":"10.1177\/23969873221094907"},{"key":"10.1016\/j.clineuro.2024.108523_bib52","unstructured":"Lawrence J. Intravenous thrombolysis in patients with ischemic stroke and DOAC intake. VJNeurology [Internet]. 2022 Aug 18 [cited 2023 Sep 7]; Available from: \u3008https:\/\/www.vjneurology.com\/intravenous-thrombolysis-in-patients-with-ischemic-stroke-and-doac-intake\/\u3009."},{"key":"10.1016\/j.clineuro.2024.108523_bib53","unstructured":"Burton K.W. Thrombolysis Safe in Stroke Patients on Oral Anticoagulants. Medscape [Internet]. 2022 May 23 [cited 2023 Sep 7]; Available from: https:\/\/www.medscape.com\/viewarticle\/974407."},{"key":"10.1016\/j.clineuro.2024.108523_bib54","unstructured":"Sylvia J. No harm of intravenous thrombolysis in stroke patients with recent use of DOACs: JAMA. 2023 Jan 18 [cited 2023 Sep 7]; Available from: https:\/\/medicaldialogues.in\/neurology-neurosurgery\/news\/no-harm-of-intravenous-thrombolysis-in-stroke-patients-with-recent-use-of-doacs-jama-105687."},{"key":"10.1016\/j.clineuro.2024.108523_bib55","unstructured":"Widdows M. Evidence on safety of intravenous thrombolysis for ischemic stroke following recent direct oral anticoagulant treatment. Neurodiem [Internet]. 2023 Jan 30 [cited 2023 Sep 7]; Available from: https:\/\/www.neurodiem.com\/news\/evidence-on-safety-of-intravenous-thrombolysis-for-ischemic-stroke-following-2nmYwXyclUAg8Cc57wMLOe."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108523_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.NT.0000921160.16523.b7","article-title":"IV Thrombolysis appears safe in people who take oral anticoagulants after ischemic stroke","volume":"23","author":"Fitzgerald","year":"2023","journal-title":"Neurol. Today"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0404.2000.00005.x","article-title":"Lacunar infarcts in patients aged 85 years and older","volume":"101","author":"Arboix","year":"2000","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108523_bib58","first-page":"101","article-title":"Gender predicts differences in acute ischemic cardioembolic stroke profile: emphasis on woman-specific clinical data and early outcome-the experience of sagrat cor hospital of barcelona stroke registry","volume":"60","author":"Inog\u00e9s","year":"2024","journal-title":"Med Kaunas. Lith."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724004104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724004104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T21:07:05Z","timestamp":1730322425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724004104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":58,"alternative-id":["S0303846724004104"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108523","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108523"}}